The shares were sold at a price of $5.64, for a total value of $21,369. InvestingPro analysis reveals 10+ additional insights about Recursion’s financial health and valuation, available in the ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a $2.48 billion market cap biotech company, saw Chief Executive Officer Christopher Gibson sell 617,875 shares of Class A Common Stock on August 11, 2025 ...

A team led by Regina Barzilay, a computer science professor at the Massachusetts Institute of Technology, has launched Boltz-2, an algorithm that unites protein folding and prediction of ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Cryptographic hash functions secure data by providing a unique fixed-length output for each input. These functions are essential in blockchain for data integrity and secure transactions. Understanding ...

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and 9 ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...